We observed this cooperative effect across multiple different models and phenotypes: loss of NF2 synergized with RIT1M90I in the PC9 erlotinib resistance assay and promoted tumor formation of human SALE cells in vivo. The gene discussed is NF2; the disease is neoplasm.